Equities
Health CareMedical Equipment and Services
  • Price (USD)289.02
  • Today's Change8.89 / 3.17%
  • Shares traded7.07k
  • 1 Year change-38.14%
  • Beta0.9299
Data delayed at least 15 minutes, as of Apr 23 2024 14:33 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade, Bio Rad Laboratories Inc (BIO:NYQ) traded at 289.02, 10.49% above the 52 week low of 261.59 set on Oct 30, 2023.
52-week range
Today
261.59Oct 30 2023473.50May 03 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open286.04
High289.11
Low284.05
Bid288.02
Offer289.11
Previous close280.13
Average volume233.26k
Shares outstanding33.61m
Free float25.07m
P/E (TTM)--
Market cap9.42bn USD
EPS (TTM)-21.49
USD
Data delayed at least 15 minutes, as of Apr 23 2024 14:33 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.